NCT03266419 - Effectiveness of Deep Versus Moderate Neuromuscular Blockade | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

March 28, 2018

Primary Completion Date

November 1, 2018

Study Completion Date

November 2, 2018

Conditions

Neuromuscular Blockade

Interventions

DRUG

Deep NMB using rocuronium

"* Drug: rocuronium~* Bolus dose: 0.7 mg/kg~* Continuous infusion : 0.8-1.2 mg/kg/h for maintaining deep NMB (post tetanic count 1-2) during operation."

DRUG

Moderate NMB using rocuronium

"* Drug: rocuronium~* Bolus dose: none~* Continuous infusion: 0.2-0.6 mg/kg/h for maintaining moderate NMB (train of four 1-2) during operation."

Trial Locations (1)

05505

Asan Medical Center, Seoul